[1]陈辅萍,彭 琦△.肺力咳胶囊联合沙丁胺醇治疗慢性阻塞性肺疾病疗效及对患者肺功能的影响[J].陕西中医,2020,(9):1228-1230.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
 CHEN Fuping,PENG Qi..Effect of Feilike capsule combined with salbutamol on chronic obstructive pulmonary disease and pulmonary function[J].,2020,(9):1228-1230.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.014]
点击复制

肺力咳胶囊联合沙丁胺醇治疗慢性阻塞性肺疾病疗效及对患者肺功能的影响
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年9期
页码:
1228-1230
栏目:
临床研究
出版日期:
2020-09-05

文章信息/Info

Title:
Effect of Feilike capsule combined with salbutamol on chronic obstructive pulmonary disease and pulmonary function
作者:
陈辅萍彭 琦
陕西省商洛市中心医院(商洛 726000)
Author(s):
CHEN FupingPENG Qi.
Shangluo Central Hospital in Shaanxi Province(Shangluo 726000)
关键词:
沙丁胺醇 肺力咳胶囊 慢性阻塞性肺疾病 肺功能 炎性反应
Keywords:
Salbutamol Feilike capsule Chronic obstructive pulmonary disease Pulmonary function Inflammatory reaction
分类号:
R563
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.014
文献标志码:
A
摘要:
目的:探讨肺力咳胶囊联合沙丁胺醇治疗慢性阻塞性肺疾病(COPD)疗效及对患者肺功能影响。方法:选取80例COPD患者为研究对象,根据不同治疗方法分为研究组和对照组,每组患者40例。对照组患者采取沙丁胺醇治疗,研究组患者采取肺力咳胶囊联合沙丁胺醇治疗。比较两组患者临床疗效和肺功能。结果:研究组患者的治疗总有效率高于对照组(P<0.05)。两组患者治疗后TNF-α、hs-CRP、IL-4、FEV1、FVC、PEF均改善,且研究组患者各炎性指标均低于对照组,各肺功能指标均高于对照组,两组比较差异均具有统计学意义(P<0.05)。研究组和对照组不良反应发生率分别为7.5%和10%,两组比较差异无统计学意义(P>0.05)。结论:肺力咳胶囊联合沙丁胺醇治疗COPD疗效较好,可改善患者临床症状,减少气道炎性反应,改善肺功能。
Abstract:
Objective:To explore the therapeutic effect of Feilike capsule combined with salbutamol on chronic obstructive pulmonary disease(COPD)and its effect on pulmonary function.Methods:80 patients with COPD were divided into study group and control group according to different treatment methods,40 patients in each group.The control group was treated with salbutamol,and the study group treated with Feilike capsule combined with salbutamol.The effect and lung function were compared between the two groups.Results:The treatment efficiency of the study group was significantly higher than that of the control group(P<0.05).After treatment,TNF-α,hs-CRP,IL-4,FEV1,FVC,PEF of the two groups were significantly improved.The inflammatory indicators of the study group were significantly lower than the control group,and the lung function indicators were higher than the control group.The difference between the two groups was statistically significant(P<0.05).Adverse reaction rate of the study group was 7.5%,that in the control group 10%.The difference between the two groups was not significant(P>0.05).Conclusion:Feilike capsule combined with salbutamol is effective in the treatment of COPD.It can improve the clinical symptoms of patients,reduce the incidence of airway inflammation,improve the pulmonary function.

参考文献/References:

[1] 周露茜,黎晓莹,李 允,等.呼吸肌锻炼联合无创正压通气在稳定期重度慢性阻塞性肺疾病患者中的应用[J].中国实用内科杂志,2017,66(4):63-66.
[2] 蔡惠东,潘剑蓉.沙丁胺醇联合布地奈德氧气雾化吸入与超声雾化吸入对小儿肺炎疗效及炎症因子的改善对比探析[J].检验医学与临床,2017,14(18):2745-2747.
[3] 果艳凤,吴小平,赵 敏.逐瘀通脉胶囊治疗慢性肺心病高凝状态及对肺功能疗效观察[J].陕西中医,2011,32(8):945-946.
[4] Jill A.Ohar,SS,Thomas G.Efficacy of indacaterol/glycopyrrolate in patients with COPD by airway reversibility at baseline:a pooled analysis of the flight1 and flight2 12 week studies[J].Journal of Chronic Obstructive Pulmonary Disease,2019,16(2):1-7.
[5] 郝文东,王国芳,张彩莲.喜炎平联合双水平正压无创通气治疗痰热壅肺型AECOPD合并呼吸衰竭与肺炎的疗效及对PCT,sTREM-1和生活质量的影响[J.中国实验方剂学杂志,2017,23(14):201-205.
[6] Liu L,Wu AP,Yang Y,et al.Effects of propofol on respiratory drive and patient-ventilator synchrony during pressure support ventilation in postoperative patients:a prospective study[J].Chin Med J,2017,130(10):1155-1160.
[7] 肖小兵,刁诗光,邱建武,等.小儿重症支原体肺炎阿奇霉素干预疗效及对患者免疫功能、肺功能的变化影响及其相互关系[J].陕西医学杂志,2019,48(3):56-59.
[8] 雷 蕾,周临福,王 祥.肺力咳胶囊联合异丙托溴铵治疗慢性支气管炎的临床研究[J].现代药物与临床,2018,33(12):3225-3228.
[9] 黄兴楚,李 婷.沙丁胺醇对小儿支气管哮喘急性期疗效分析[J].中国继续医学教育,2019,11(15):138-140.
[10] 吴小娜,窦 林.头孢泊肟酯胶囊联合肺力咳合剂治疗下呼吸道感染的疗效分析[J].中外女性健康研究,2017,5(17):39,44.
[11] Melina MM,Nuria CB,Bradley AM.MicroRNA dysregulation in pulmonary arteries from COPD:relationships with vascular remodeling[J].American Journal of Respiratory Cell & Molecular Biology,2018,59(4):490-499.
[12] 焦文妤,崔志军.不同他汀类药物对老年慢阻肺合并慢性肺心病患者肺功能及生活质量影响研究[J].陕西医学杂志,2018,47(8):1063-1065,1068.
[13] 杨晓鹏,李秀娟,梁金宇,等.全真一气汤对COPD模型小鼠Nrf2通路及对炎性细胞因子和肺组织超微结构的影响[J].中国实验方剂学杂志,2016,24(22):86-91.
[14] 张丹丹,刘剑南,朱选风,等.沙美特罗氟替卡松联合噻托溴铵与低剂量强的松联合氨茶碱对COPD肺心病患者心功能的影响[J].南京医学大学学报:自然科学版,2016,36(4):440-443.
[15] 吴大威,范穗强,杨玉双,等.达肺饮汤剂联合塞托溴铵治疗COPD临床疗效及血浆合肽素、hs-CRP影响[J].辽宁中医药大学学报,2018,20(5):201-204.

更新日期/Last Update: 2020-09-08